Posts in category: Uncategorized

A new study, appearing today in the New England Journal of Medicine, shows that nursing homes that conducted staff surveillance testing more regularly during the COVID-19 pandemic experienced significantly lower rates of COVID infections and deaths among residents.

A new study has found that people with epilepsy have an increased risk of early death and the increased risk varies depending on where they live, the number of medications they take and what other diseases they may have. The study is published in Neurology.

A promising cancer drug that targets only cancer cells has been developed by researchers from the Norwegian University of Science and Technology (NTNU) and a university spin-off company, APIM Therapeutics.

The Biden administration said Wednesday it will attempt to break up the network that runs the nation’s organ transplant system as part of a broader modernization effort.

Air flow in a room can impact the transmission of viruses like COVID-19.

Black and Hispanic patients consistently experience higher odds of postpartum emergency departments visits in New York state, according to a study published online March 21 in JAMA Network Open.

There are clear regional differences in the proportion of older adults receiving potentially inappropriate drug treatment in Sweden. In a study published in Frontiers of Pharmacology, researchers at Karolinska Institutet examine regional differences over time and show that these regional variations have decreased over the past decade.

Brown fat is not linked to cancer-associated loss of body weight and muscle mass, a common condition known as cachexia, according to a new joint study from The Rockefeller University and Memorial Sloan Kettering Cancer Center in New York City. In addition, researchers discovered a trend suggesting brown fat, also called brown adipose tissue, may help improve survival in people with cancer. The findings are published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.

Clinical trials are the backbone of evidence-based medicine. This is where new drugs and treatments are tested on humans for the first time. The results of such trials are therefore highly relevant. But unfortunately many clinical trial results from German universities are not published at all or are registered too late—and if they are published, the results are often not openly accessible.

Fiber intake is associated with a lower risk of developing cognitive decline in those old people with the apolipoprotein E ApoE ε4 genotype, regarded as a genetic risk factor linked to the development of Alzheimer’s disease. This is stated in a study conducted by the Research Group on Biomarkers and Nutritional and Food Metabolomics of the Faculty of Pharmacy and Health Sciences of the University of Barcelona and the CIBER on Fragility and Ageing (CIBERFES).